The aim of this study was to characterize the mechanism of the chemical interaction between L-ascorbic acid (ASC) and tetrahydrobiopterin (BH 4 ) in vitro and to examine its effect on the activity of endothelial nitric oxide synthase (eNOS) in first trimester human placentae. At room temperature, in Tris-HCl buffer (pH 7.4), both ASC and BH 4 were readily oxidized by dissolved O 2 or H 2 O 2 . BH 4 was more sensitive to auto-oxidation, while ASC was more susceptible to oxidation by H 2 O 2 . Addition of 36 µmol/l BH 4 to 143 µmol/l ASC increased the initial rate of ASC oxidation 3.2-fold in a catalase-sensitive manner, indicating that enhanced ASC oxidation is partly due to the formation of H 2 O 2 . In the presence of catalase, BH 4 still stimulated 1.9-fold the initial rate of ASC oxidation, suggesting that another auto-oxidation product of BH 4 , most probably quininoid-BH 2 (qBH 2 ), could also stimulate ASC oxidation while itself being reduced back to BH 4 . ASC prevented the auto-oxidation of BH 4 in a concentrationdependent fashion, with 3 mmol/l ASC providing an almost complete stabilization of 25 µmol/l BH 4 . Importantly, basal eNOS activity in placental microsomes was stimulated 2.5-fold by 0.5 µmol/l BH 4 , and 0.5 mmol/l ASC enhanced the BH 4 -stimulation 1.4-fold, with a smaller effect on basal eNOS activity. Taken together, the findings support the notion that the stabilizing action of ASC on BH 4 is related to the ASC-mediated reductive reversal of the auto-oxidation process of BH 4 . Moreover, we demonstrated that concentrations of ASC present in the placenta as a common vitamin C supply are sufficient to protect cellular free BH 4 and may contribute to the stimulation of placental eNOS activity.
Introduction
Tetrahydrobiopterin (BH 4 , 6, 7, is an indispensable co-factor for the activity of nitric oxide synthase (NOS) enzymes. BH 4 is an unstable compound; it undergoes auto-oxidation in aqueous solutions at pH 7.4 to form 7,8-dihydrobiopterin (BH 2 ), with tetrahydrobiopterin 4a-hydroperoxid and quininoid dihydrobiopterin (qBH 2 ) as possible intermediates (Thöny et al., 2000) .
A close link between cellular BH 4 concentrations and NO synthesis has been described for a number of different cell types including endothelial cells and placental syncytiotrophoblasts (Schmidt et al., 1992; Conrad et al., 1993; Myatt et al., 1993a; Werner-Felmayer et al., 1993; Buttery et al., 1994; RosenkranzWeiss et al., 1994; Kukor et al., 1996 Kukor et al., , 2000 Tóth et al., 1997) . Moreover, BH 4 supplementation has been demonstrated to restore or improve endothelium-dependent vasodilation in several pathological states including atherosclerosis (Tiefenbacher et al., 2000) , reperfusion injury following tran-sient coronary occlusion (Tiefenbacher et al., 1996) , diabetes mellitus (Pieper, 1997) , hypercholesterolaemia (Stroes et al., 1997) and vascular dysfunctions of chronic smokers (Heitzer et al., 2000; Ueda et al., 2000) .
Ascorbic acid, one of the most important water-soluble physiological antioxidants, has also been shown to improve endothelial vasodilating functions in atherosclerosis (Levine et al., 1996; Ness et al., 1996a; Gokce et al., 1999; Frei, 1999) ; diabetes mellitus (Ting et al., 1996; Timimi et al., 1998) and hypercholesterolaemia (Ting et al., 1997; Jeserich et al., 1999) and to alleviate the endothelial dysfunction of chronic smokers (Heitzer et al., 1996) . In addition, a number of studies have concluded or suggested that a low plasma ascorbic acid level (taken as an indicator of vitamin C deficiency) is a risk factor for coronary heart disease (Riemersma et al., 1991; Enstrom et al., 1992; Gey et al., 1993; Ness et al., 1996b; Nyyssönen et al., 1997; Vita et al., 1998) and stroke (Gey et al., 1993; Gale et al., 1995) . Of particular interest are the observations that ascorbic acid may contribute to the lowering of blood pressure (Ness et al., 1996c (Ness et al., , 1997 Frei, 1999) .
Low ascorbic acid levels have been reported by several laboratories (Mikhail et al., 1994; Hubel et al., 1997; Sagol et al., 1999; Kharb, 2000) in pre-eclampsia. This finding is not surprising since increased oxidative stress appears to be a cardinal factor in the pathogenesis of this hypertensive disorder (Davidge, 1998; Dekker and Sibai, 1998; Hubel, 1999) . Combined antioxidant therapy protocols including high doses of vitamin C and vitamin E have led to some beneficial effects in pre-eclamptic patients (Gulmezoglu et al., 1997; Chappell et al., 1999) .
An explanation for the related vascular effects of BH 4 and ascorbic acid has emerged from the observations that ascorbic acid potentiates NO synthesis in a BH 4 -dependent manner in endothelial cells obtained from human umbilical veins and coronary arteries (Heller et al., 1999) , or from porcine aorta (Huang et al., 2000) . Similar effects have been observed in vitro using purified recombinant bovine eNOS (Huang et al., 2000) . Further studies have revealed that treatment of endothelial cells with physiological concentrations of ascorbic acid leads to an increase in intracellular BH 4 levels and this effect can be ascribed solely to a chemical stabilization of this cofactor (Baker et al., 2001; Heller et al., 2001) .
In this study, first we examined how ascorbic acid and BH 4 , which are two auto-oxidizable compounds, interact with each other and how this interaction results in chemical protection of BH 4 . We conclude that O 2 reacts with BH 4 more avidly than with ascorbic acid, and ascorbic acid exerts a direct reducing effect on the oxidation product of BH 4 , presumably on qBH 2 . Ascorbic acid also efficiently removes H 2 O 2 , the main product of BH 4 auto-oxidation, and a powerful oxidant. Furthermore, we provide evidence that ascorbic acid potentiates the stimulatory effect of BH 4 on placental eNOS activity in vitro. Finally, determinations of ascorbic acid concentrations in placental tissues obtained from different pregnancies confirm that the BH 4 -stabilizing chemical effect of ascorbic acid might be functional under physiological conditions.
Materials and methods

Materials
L-[U-14 C]arginine (298 mCi/mmol; 11 GBq/mmol) was obtained from ICN (Costa Mesa, CA, USA). L-ascorbic acid, Tris base, EDTA and hydrogen peroxide (H 2 O 2 ) were purchased from REANAL (Budapest, Hungary). Tetrahydrobiopterin, biopterin, crystalline catalase from bovine liver, L-N G -nitroarginine methylester (NAME), ethyleneglycol-bis(β-aminoethylether)-N-tetra-acetate (EGTA), NADPH, Dowex 50X8-400, dithiotreitol (DTT), citrulline, calmodulin, leupeptin, soybean trypsin inhibitor and aprotinin were from Sigma Chemical Co. (Budapest, Hungary). Phenylmethylsulphonylfluoride (PMSF) and HEPES were from Calbiochem (La Jolla, CA, USA). Reagents were prepared with double-distilled deionized water. L-ascorbic acid and BH 4 stock solutions were prepared in 0.1 mmol/l HCl and aliquots were stored at -30°C. Ascorbic acid was diluted prior to experiments with 50 mmol/l TrisHCl (pH 7.4). Concentrations of H 2 O 2 stock solutions were determined by permanganometric titration.
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Measurement of ascorbic acid oxidation To determine the rate of auto-oxidation, ascorbic acid (100 or 143 µmol/l final concentration) was dissolved in 3.5 ml of 50 mmol/l Tris-HCl (pH 7.4) or 50 mmol/l Tris-HCl, 50 µmol/l or 0.5 mmol/l EDTA (pH 7.4) buffer. A decrease in optical absorbance at 265 nm was monitored in the presence or absence of 25 or 36 µmol/l BH 4 or catalase (8.6, 17.2 or 27.1 µg/ml) or H 2 O 2 (0.06, 0.30 or 1.20 mmol/l) at 22°C, using a Hitachi U-2001 double beam spectrophotometer. The concentration of oxidized ascorbic acid was calculated from the decrease in absorbance at 265 nm using the molar extinction coefficient of 16 500 for ascorbic acid (Davies et al., 1991) .
Measurement of BH 4 oxidation
Oxidation of BH 4 was followed by monitoring the decrease of absorbance at 295 nm at 22°C. The concentration of oxidized BH 4 was calculated using a molar extinction coefficient of 5500 (M.Tóth, unpublished data). In the presence of ascorbic acid, auto-oxidation of BH 4 was studied by measuring the absorbance decrease at 305 nm where the interference by absorption of ascorbic acid was negligible and concentration changes were calculated on a percentage basis. Incubations were initiated by adding an appropriate volume of BH 4 to a freshly diluted ascorbic acid solution or incubation buffer to reach a final volume of 3.5 ml. Where indicated, H 2 O 2 (0.06, 0.3 and 1.2 mmol/l) or catalase (8.6 or 17.2 µg/ml) were included in the incubation mixtures.
Tissue, homogenization and fractionation
First trimester human placentae from legal instrumental termination of 9-11 week old pregnancies were obtained from the 2nd Department of Obstetrics and Gynecology, Semmelweis University, Budapest. Use of the placentae for these experiments has been approved by the Ethics Committee of the clinical department and informed consent was given by each patient. Minced villous placentae were homogenized in two volumes of ice-cold homogenizing solution containing 0.3 mol/l sucrose, 40 mmol/l HEPES-Na (pH 7.4), 0.1 mmol/l EDTA, 1 mmol/l DTT, 1 mmol/l PMSF, 10 µg/ml leupeptin, 10 µg/ml soybean trypsin inhibitor and 0.2 µg/ml aprotinin, using an UltraTurrax apparatus (IKA Werk, Staufen, Germany) at the three-quarter setting for 30 s. The homogenate was filtered through a nylon mesh and subjected to centrifugation at 15 000 g for 30 min in a Beckman J-21 centrifuge. The supernatant was then centrifuged at 100 000 g for 60 min in a Beckman L2-65B ultracentrifuge to obtain the microsomal pellet. The pellet was rinsed three times with DTT-free homogenizing solution and suspended in a small volume of the same solution. Four sets of microsomes were prepared from placental tissues obtained from each of three first-trimester human pregnancies and stored at -80°C until measurement of enzyme activity.
Measurement of NO synthase activity NOS activity was determined by measuring the rate of conversion of [ 14 C]arginine into [ 14 C]citrulline. 100 µl tissue extract containing 1.4-1.8 mg protein was incubated with 0.15 µCi [ 14 C]arginine (2 µmol/l final concentration), 0.4 mmol/l NADPH, 1 mmol/l citrulline, 1 mmol/l MgCl 2 , 1 mmol/l CaCl 2 , 0.1 mmol/l EGTA, 3 IU calmodulin, 20 mmol/l HEPES-Na (pH 7.4) and BH 4 and ascorbic acid as indicated, in 250 µl final volume for 15 min at 37°C. Incubations were run in duplicates. Control incubates contained 1 mmol/l EGTA without Ca 2ϩ added. In separate control incubations, 1 mmol/l EGTA and 1 mmol/l L-NAME were present in the absence of exogenous Ca 2ϩ in order to measure Ca 2ϩ -independent citrulline formation which was negligible in these experiments. [ 14 C]citrulline was separated from [ 14 C]arginine on small columns of Dowex 50X8-400 cation exchange resin and radioactivity was measured using a Packard Tri-Carb 2100 TR liquid scintillation analyzer. Measured radioactivities were corrected for the mean of the radioactivity values of controls and eNOS activity was calculated as disintegrations/min (d.p.m.) of incubation per mg of protein. Finally, from the duplicate results the mean value Ϯ SD from the mean was computed. Experiments were repeated three times with different microsomal preparations, the results were normalized to the mean of activity values obtained in the absence of BH 4 and ASC and subjected to statistical analysis.
Determination of placental concentration of ascorbate
For determination of total ascorbic acid (i.e. ascorbic ϩ dehydroascorbic acids), a published procedure (Denson and Bowers, 1961) was used. The method measures ascorbic acid in TCA extracts after oxidation by Cu 2ϩ ions and conjugation with 2,4-dinitrophenylhydrazine. Triplicate placental pieces (1 g each), obtained at term from normal pregnancies or from first trimester pregnancies after legal interruption, were homogenized in 10% TCA with an all-glass Potter-Elvehjem homogenizer and the TCA-soluble fraction was collected by centrifugation. The TCA concentration of the extract was adjusted to 5% and asorbic acid was measured from duplicate aliquots. A calibration line was prepared using pure ascorbic acid dissolved in 5% TCA.
Ascorbic acid was determined using the dipyridyl method (Omaye et al., 1979) . The procedure is based on the quantitative oxidation of ascorbic acid by Fe 3ϩ and the subsequent conversion of Fe 2ϩ with dipyridyl into an orange-yellow chelate complex. Placental pieces (1 g each) were homogenized in 4 ml ice-cold 0.9% NaCl, 100 µmol/l EDTA solution using the UltraTurrax apparatus mentioned above, the homogenate was briefly centrifuged in the cold and a 1.0 ml clear aliquot from the supernatant was added to 4 ml 5% TCA, 50 µmol/l EDTA. After centrifugation, ascorbic acid determinations were made from aliquots of the clear supernatant. Calibration line was prepared from ascorbic acid dissolved in 5% TCA, 50 µmol/l EDTA solution.
Determination of protein
Protein was measured by a published method (Lowry et al., 1951) using bovine serum albumin as standard.
Statistical analysis
For statistical evaluation of data, one-way analysis of variance followed by Bonferroni's t-test or Wilcoxon's unpaired t-test was used. P Ͻ 0.05 was considered to be statistically significant. For comparison of reaction rates of ascorbic acid oxidation, the initial rate was used. The reaction rate was regarded initial as far as it was directly proportional to the reaction time.
Results
Effect of auto-oxidation on the absorption spectra of ascorbic acid and BH 4
The UV spectrum of ascorbic acid at pH 7.4 exhibited a high absorption peak with a maximum at 265 nm ( Figure 1A ). Oxidation of ascorbic acid led to a loss of this absorption band (data not shown), therefore, ascorbic acid oxidation was determined by monitoring the optical density at 265 nm.
The UV absorption spectra of BH 4 before and after incubation in Tris-HCl (pH 7.4) at room temperature for 40 min were studied ( Figure 1B ). The spectrum of BH 4 exhibited characteristic changes as BH 4 was rapidly auto-273 oxidized. Apparently, complete oxidation of BH 4 to biopterin did not occur, because the absorption spectrum of biopterin is different from the spectrum obtained for BH 4 after incubation. The decrease in absorption of BH 4 at 295 nm during oxidation offered a convenient way to monitor this process.
Inclusion of 25 µmol/l BH 4 in an ascorbic acid solution of 100 µmol/l resulted in only a slight absorption elevation at 300 nm ( Figure 1A ). This elevation was due to the absorption of BH 4 and it allowed selective monitoring of BH 4 autooxidation at 305 nm without substantial interference by light absorption of ascorbic acid. At the same time, oxidation of ascorbic acid could still be quantified by measuring the decrease in absorption at 265 nm, since BH 4 and BH 2 show a similar quench at 265 nm ( Figure 1B ) and redox changes of BH 4 do not interfere at this wavelength.
Oxidation of ascorbic acid and BH 4 by O 2 or H 2 O 2 dissolved in the medium
Ascorbic acid (100 µmol/l final concentration) underwent fairly rapid auto-oxidation at pH 7.4 with a half-time (T 1/2 ) of 35 min and the rate of this change was only slightly influenced by the presence of 25 µmol/l BH 4 (Figure 2A ). On the other hand, inclusion of 50 µmol/l EDTA in the buffered solution markedly reduced the rate of auto-oxidation (T 1/2 Ͼ 120 min), indicating that metal contaminants present in the buffer enhance autooxidation of ascorbic acid. Under these conditions, BH 4 exerted a 1.8-fold stimulatory effect on ascorbic acid oxidation ( Figure 2B ).
The reactivity of ascorbic acid and BH 4 with H 2 O 2 was also studied. Oxidation of ascorbic acid (36 µmol/l) was accelerated markedly by low concentrations of H 2 O 2 ( Figure 3A) while the effect of H 2 O 2 on BH 4 (36 µmol/l) was much smaller ( Figure 3B ). For instance, 60 µmol/l H 2 O 2 resulted in 3-fold and 1.2-fold acceleration in the initial rate of ascorbic acid and BH 4 auto-oxidation respectively. Taken together, Figures 2 and 3 clearly demonstrate that: (i) BH 4 reacts faster with O 2 than does ascorbic acid (i.e. BH 4 is more susceptible to autooxidation than is ascorbic acid); (ii) the opposite holds true for H 2 O 2 : BH 4 oxidation is only slightly increased, whereas ascorbic acid oxidation is significantly enhanced, in response to H 2 O 2 .
In order to compare the contribution of H 2 O 2 , formed during auto-oxidation of both ascorbic acid and BH 4 , to the oxidation of these compounds, the effect of catalase on the initial rate of their auto-oxidation was also studied. The oxidation rate of ascorbic acid was inhibited by 8.6 and 17.2 µg/ml catalase at 38.7 and 51.9% respectively, in the presence of 50 µmol/l EDTA ( Figure 4A ). This value definitely exceeded the 25% catalase-induced decrease in the initial rate of BH 4 autooxidation measured under the same conditions ( Figure 4B ). Evidently, ascorbic acid is more sensitive than BH 4 to the H 2 O 2 generated during the auto-oxidation of these compounds.
Ascorbic acid protects BH 4 against oxidation
In order to gain insight into the redox mechanisms between ascorbic acid and BH 4 , the effect of catalase on the spontaneous and the BH 4 -promoted ascorbic acid oxidation was studied using the standard experimental conditions (using 100 µmol/l ascorbic acid, 25 µmol/l BH 4 and 50 µmol/l EDTA). BH 4 increased 1.8-fold the initial rate of ascorbic acid oxidation. In the presence of 8.6 µg/ml catalase, the rate of BH 4 -dependent ascorbic acid oxidation decreased markedly, and some attenuation of the BH 4 -independent auto-oxidation of ascorbic acid also occurred (data not shown). However, in the presence of 8.6 µg/ml catalase, the rate of ascorbic acid oxidation measured in the presence of BH 4 was 1.25-fold the rate of ascorbic acid oxidation determined in the absence of BH 4 . This definite rate difference did not change in the presence of a 2-fold concentration (17.2 µg/ml) of catalase indicating that incomplete removal of H 2 O 2 was not responsible for the observed residual oxidation of ascorbic acid (data not shown). These observations seemed to reflect a crucial H 2 O 2 -independent interaction between BH 4 auto-oxidation and 274 ascorbic acid oxidation. In order to support the validity of this finding, a series of further measurements was performed. With the aim to increase the effect of BH 4 on ascorbate oxidation in the presence of catalase, in these experiments the concentrations of ascorbic acid, BH 4 and EDTA in the incubation medium were enhanced to 143 and 36 µmol and 0.5 mmol/l respectively. In addition, four series of experiments with duplicate incubations each were performed and the results were subjected to statistical analysis. The results indicated an extremely significant~2-fold BH 4 -dependent increase in the initial rate of ascorbic acid oxidation in the presence of 27.1 µg/ml catalase ( Figure 5 ). This oxidation could not be caused by incomplete removal of H 2 O 2 , because another series of control experiments clearly demonstrated that concentrations of catalase in the range of 17.2-27.1 µg/ml (smaller concentra- tions were not studied) completely prevent the oxidation of ascorbate by 60 µmol/l H 2 O 2 (data not shown). These results indicated that H 2 O 2 released from the auto-oxidation of BH 4 is an important, but not the only, factor leading to oxidation of ascorbic acid. Since in the presence of catalase BH 4 still accelerated up to 2-fold the oxidation rate of ascorbic acid, we concluded that beside H 2 O 2 , BH 2 (or rather the quininoid-BH 2 intermediate of BH 4 auto-oxidation) was also able to oxidize ascorbic acid. Because in the absence of H 2 O 2 only BH 2 (or qBH 2 ) is present in the system as a redox reaction partner for ascorbic acid, it is reasonable to suggest that ascorbic acid reduced this compound to form BH 4 .
In order to demonstrate the protective effect of ascorbic acid on net BH 4 oxidation, BH 4 stability was measured in the presence of various concentrations of ascorbic acid (Figure 6 ). In these measurements, EDTA was not included in the incubated mixtures and ascorbic acid solutions at the tested 275 concentrations were used as photometric blanks (i.e. test solutions and blank solutions contained the same concentration of ascorbic acid). Since in the absence of EDTA there is only negligible difference between the rates of oxidation of ascorbic acid measured either in the presence or absence of 25 µmol/l BH 4 (Figure 2A) , possible interference by optical absorption of ascorbic acid with the BH 4 absorption measured at 305 nm was largely eliminated. As shown by Figure 6 , ascorbic acid inhibits BH 4 auto-oxidation in a concentration-dependent fashion with 3 mmol/l ascorbic acid providing an almost perfect stabilization of 25 µmol/l BH 4 .
Ascorbic acid stimulates microsomal eNOS activity of the human placenta
Keeping in mind the definite protective action of ascorbic acid on BH 4 in vitro, the protective effect of ascorbic acid on eNOS activity of placental microsomes was investigated. In these . BH 4 (25 µmol/l) was incubated at 22°C in the absence (squares) or in the presence of 0.5 mmol/l (diamonds) or 1.5 mmol/l (triangles) or 3 mmol/l (circles) final concentration of ASC in 50 mmol/l Tris-HCl, pH 7.4 for the time periods indicated and the optical density at 305 nm was recorded. ASC concentrations of blank solutions were exactly identical to that of the test solutions. Mean values Ϯ SD (n ϭ 4-6) are presented. Statistical analysis (ANOVA followed by Bonferroni's t-test) on the basis of the initial rates of decomposition: 0.5 mmol/l ASC versus control or 1.5 mmol/l ASC: P Ͼ 0.05 (not significant); 1.5 mmol/l ASC versus control: P Ͻ 0.01; 3.0 mmol/l ASC versus control: P Ͻ 0.001; 3.0 mmol/l ASC versus 0.5 or 1.5 mmol/l ASC: P Ͻ 0.01. experiments the otherwise routinely used DTT was omitted, since the strong reducing power of this non-physiological dithiol would mask the protective effect of ascorbic acid. In addition, EGTA (100 µmol/l final concentration) was included in the incubation mixtures to protect ascorbic acid against metal-catalysed auto-oxidation. Physiological BH 4 concentrations stimulated eNOS activity 2.5-fold, and ascorbic acid afforded an additional 1.4-fold increase in the BH 4 -stimulatable eNOS activity (Figure 7) . The activity increase was maximal at 500 µmol/l ascorbic acid ( Figure 7A ) and at 200-500 nmol/l BH 4 ( Figure 7B) concentrations. However, a significant increase of enzyme activity was observed already at 100 µmol/l ascorbic acid concentration ( Figure 7A ).
Ascorbic acid concentrations in the human placenta
First trimester and term human placentae contained 117.4 Ϯ 12.5 µmol/kg (mean Ϯ SD, n ϭ 3 placentae) and 254.5 Ϯ 85.2 µmol/kg tissue (mean Ϯ SEM, n ϭ 7 placentae) ascorbic acid when measured as the dehydroascorbic acid form. Determination of ascorbic acid on the basis of its reducing capacity (314.3 Ϯ 47.5 µmol/kg, mean Ϯ SEM, n ϭ 7) did not show a statistically significant difference (P ϭ 0.5513). This finding indicates that most of the ascorbic acid is present in reduced form in placental tissues and in sufficient concentrations to exert a protective effect on autooxidative BH 4 inactivation.
Discussion
NO is produced during human pregnancy by type III (endothelial) NOS (Conrad et al., 1993; Garvey et al., 1994; Gude et al., 1994; Kukor and Tóth, 1994; Tóth et al., 1995) in syncytiotrophoblasts and in the endothelial cells of the umbilical and villous blood vessels (Conrad et al., 1993; Myatt et al., 1993a,b; Buttery et al., 1994; Eis et al., 1995) . Adequate NO production is considered to be important in the maintenance of feto-placental and materno-placental perfusion and in the adaptation of maternal circulation by vasodilation and blood pressure decrease to the expanded blood volume during pregnancy (Gude et al., 1990; Myatt et al., 1991 Myatt et al., , 1992 Chaudhuri et al., 1993; Hull et al., 1994; Rutherford et al., 1995) . Our previous results have indicated that eNOS of human placenta is not saturated with BH 4 , therefore elevation of BH 4 levels can stimulate enzyme activity and NO production in placental tissues (Kukor et al., 1996 (Kukor et al., , 2000 Sahin-Tóth et al., 1997; Tóth et al., 1997 Tóth et al., , 1998 . eNOS is active as a dimer and, similarly to neuronal NOS (Gorren et al., 1996; Riethmüller et al., 1999) and inducible NOS (Mayer et al., 1997) , one of its subunits appears to bind BH 4 tightly, while the affinity of the second subunit to BH 4 is much lower and the binding concentrations fall within the tissue concentration range of BH 4 (Tóth et al., 1998; Kukor et al., 2000) . Consequently, variations in cellular BH 4 concentrations can regulate NO production via the second subunit of eNOS. Decreased availability of BH 4 may cause uncoupling of oxygen reduction and arginine oxidation by eNOS and may lead to generation of superoxide anions and subsequently H 2 O 2 (Stroes et al., 1998; Vásquez-Vivar et al., 1998; Xia et al., 1998 ; Leber et al., 1999). Thus BH 4 deficiency may cause both impaired NO formation and increased production of oxygen radicals. Moreover, NO and superoxide can combine with each other to form peroxynitrite (ONOO -), an aggressive oxidant (Beckman and Koppenol, 1996; Cosentino and Lüscher, 1998) . Coupled with NO inactivation, the formation of peroxynitrite may constitute a serious risk factor for hypertension and atherosclerosis and, in the case of pregnancy, for placental ischaemia, a putative cause of pre-eclampsia (Davidge, 1998; Dekker and Sibai, 1998; Hubel, 1999; Lowe, 2000) . We have proposed recently that diminished binding affinity of BH 4 to the 'second' subunit of placental eNOS may play a role in the pathogenesis of preeclampsia through promoting the production of abnormally large quantities of O 2 -and peroxynitrite (Kukor et al., 2000) . Because BH 4 is sensitive to oxidative agents and can easily react with molecular oxygen even at ambient temperature, a potentially feasible approach to protect BH 4 under various conditions of oxidative stress could be the application of natural antioxidants such as ascorbic acid (vitamin C). According to recently reported experimental observations, ascorbic acid treatment of endothelial cells leads to an increase in intracellular BH 4 levels and this effect is due to chemical stabilization of the fully reduced form of the pterin (Heller et al., 1999 (Heller et al., , 2001 Huang et al., 2000; Baker et al., 2001) . These findings validated the usefulness of vitamin C supplementation for preventing vascular damages and justified the administration of vitamin C in order to help prevent endothelial dysfunction or restore normal endothelial functions (Heitzer et al., 1996; Levine et al., 1996; Ting et al., 1996 Ting et al., , 1997 Timimi et al., 1998; Gokce et al., 1999; Jeserich et al., 1999) . In the same context, ascorbic acid may contribute to the maintenance of satisfactory eNOS activity in the human placenta, thereby reducing the risk of placental dysfunctions or improving placental functions in pathological pregnancies (Gulmezoglu et al., 1997; Chappell et al., 1999) .
The present findings confirm the BH 4 -stabilizing antioxidant effect of ascorbic acid and shed some light on its chemical mechanism. Although ascorbic acid itself is an antioxidant, it reacts readily with O 2 and produces H 2 O 2 , a potent oxidant. The BH 4 -protective antioxidant effect of ascorbic acid may result from at least three mechanisms. (i) Elimination of O 2 from the solvent. In this respect, competition for O 2 as an antioxidant mechanism of ascorbic acid is unlikely, because simultaneous auto-oxidation of 25 µmol/l BH 4 and 100 µmol/l ascorbic acid could proceed in the same solution ( Figure 5 ). Moreover, O 2 had a greater affinity toward BH 4 than toward ascorbic acid. (ii) Consumption of H 2 O 2 via reduction. Indeed, ascorbic acid reacted with H 2 O 2 readily ( Figure 3A) , and catalase dramatically decreased oxidation of ascorbic acid incubated with BH 4 (Figure 5 ), suggesting that H 2 O 2 formed by the auto-oxidation of BH 4 is consumed by ascorbic acid. However, in the presence of O 2 dissolved in the incubation medium, BH 4 was relatively insensitive to oxidation by H 2 O 2 , as its auto-oxidation was only marginally increased by H 2 O 2 ( Figure 3B ) and only slightly decreased by catalase ( Figure  4B ). Therefore, elimination of H 2 O 2 by ascorbic acid does not contribute to the chemical stabilization of BH 4 to any significant extent. (iii) Direct reduction of BH 2 to regenerate BH 4 with the concomitant formation of dehydroascorbic acid. Our results suggest the existence of this mechanism. Thus, incubation of ascorbic acid with BH 4 markedly increased (~3-fold) the rate of ascorbic acid oxidation and a major part of this increase was abolished by catalase, indicating that this part is mediated by H 2 O 2 ( Figure 5 ). Importantly, in the presence of catalase (which was shown to prevent completely the oxidation of ascorbic acid by H 2 O 2 ), BH 4 still stimulated the rate of ascorbic acid oxidation by a factor of~2 ( Figure 5 ), demonstrating that a portion of the BH 4 -stimulated ascorbic acid oxidation is not mediated by H 2 O 2 . Although BH 4 concentrations were not measured in these experiments, this part of increased ascorbic acid oxidation may be accounted for by the direct reduction of BH 2 (or rather the quininoid-BH 2 intermediate of the autooxidation process) to BH 4 , since, under the conditions used, BH 2 was the only redox reaction partner for ascorbic acid. Because regenerated BH 4 is subject to repeated auto-oxidation, we propose that the reaction cycle recurs, continuously producing dehydroascorbic acid from ascorbic acid and O 2 , while BH 4 concentrations remain approximately constant. Chemically, the overall process can be described as 'BH 4 -catalysed oxidation of ascorbic acid' (Figure 8 ).
An important question is whether or not the in-vitro chemical stabilization of BH 4 by ascorbic acid is physiologically relevant. In our studies, 3 mmol/l ascorbic acid exerted an almost complete protective effect on 25 µmol/l BH 4 in the absence of EDTA, indicating that a 120-fold molar excess of ascorbic acid is sufficient for BH 4 protection. Average tissue concentrations of BH 4 in human placentae from first trimester and term pregnancies are 0.189 and 0.057 µmol/l respectively (Kukor et al., 2000) . These values suggest that ascorbic acid concentrations as low as 7 µmol/l in term placentae or 23 µmol/l in primordial placentae can have significant protective effects in vivo. Importantly, these ascorbic acid concentrations are well within the range of vitamin C levels we measured in placental tissues, indicating that ascorbic acid may play a physiological role in the regulation of eNOS activity. In this respect, our invitro studies with placental eNOS enzyme clearly show that the protective effect of ascorbic acid on BH 4 can lead to elevated enzyme activity. In agreement with reports from other laboratories (Heller et al., 1999 (Heller et al., , 2001 Huang et al., 2000) , the ascorbic acid dependent activity increase was not detectable at high, unphysiological BH 4 concentrations.
Vitamin C is evidently an important daily dietary supplement during pregnancy, and among other effects it may have a beneficial influence on placental and vascular functions. In some of the pre-eclamptic patients, failure to show significant 278 improvements in response to regular vitamin C administration may stem from the malfunction of their placental eNOS enzyme. In a previous study (Kukor et al., 2000) we have found that the homogenates of seven out of 10 placentae obtained from pre-eclamptic pregnancies contain eNOS enzyme that is resistant to the stimulatory effect of 0.025-1.00 µmol/l BH 4 , while the basal activity is sustained. This malfunction could not be corrected by elevated BH 4 concentrations, therefore in these cases increased vitamin C supply cannot alleviate the characteristic pre-eclamptic symptoms. On the other hand, in pre-eclamptic patients with functionally normal BH 4 -responsive placental eNOS, one may expect beneficial protective and preventive effects from sustained vitamin C supplementation during pregnancy.
